FLT4 blockade can likely reduce the level of inflammation and reactivity of glial cells, since VEGFR-3 could be involved in the development of the inflammatory response of astrocytes in ischemic strokes [28,29]. This evidence concerns the gene FLT4 and ischemic stroke.